학술논문

Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial
Document Type
Article
Source
In: Vaccine: X. (Vaccine: X, 11 December 2020, 6)
Subject
Language
English
ISSN
25901362